SBA 7(a) Behavioral Health Feasibility Study in California

California leads the nation, with larger loans

California ranks 1 among states for SBA 7(a) behavioral health and addiction treatment loans. SBA approved 124 of them from FY2017 to FY2026, for $129.0 million, though the class stands only 21 of 39 within California's own lending. What sets the cell apart from its parents is size: the median of $491,400 is 1.97x the nationwide figure for the pairing, with the central band reaching from $150,000 up to $1.5 million. Franchise brands play no part, at 0.00% of loans. Treatment providers in California borrow nearly twice as much per loan as their peers elsewhere, a reflection of facility costs, licensing and staffing.

Who lends and where

Wells Fargo Bank National Association leads on count (13 loans, $6.3 million), then U.S. Bank, National Association (11 loans, $8.4 million), Northeast Bank has 7 ($1.7 million), The Huntington National Bank 6 ($3.4 million) and Enterprise Bank & Trust 5 ($5.6 million). No one lender dominates, and the dollar totals show mixed ticket sizes. Los Angeles County has 49 loans, Orange County 27 and San Diego 14, so the southern coast carries most of the record, with Ventura at 5 and Riverside, Sacramento, San Bernardino and Sonoma at 4 each. Volume grew late in the period: 18 loans and $13.6 million in FY2024, 23 and $16.4 million in FY2025, and 18 and $22.7 million in FY2026.

At least 13.3% of California loans approved in FY2017 through FY2024 were dropped before funding, and up to 14.5% if undisbursed loans are included. Across the 42 loans in the funded group from FY2017 to FY2021 approvals, the floor on write-offs is 2.4%, identical for the running and five-year measures. Small cohort, minimum values: read them that way.

Testing a California treatment request

Mental health and addiction treatment share both industry codes and cannot be separated, so the record covers a mixed group of providers: outpatient clinics, residential programmes and counselling practices. A California study must say which model the project is. It should test referral sources, payer mix and reimbursement rates, licensing and the time needed to obtain it, clinician recruitment, and neighbourhood approval for residential use, which can decide whether a site is usable at all. Building cost and equipment should be reconciled to a ticket near the large median, and payments covered through a slow census ramp. The appraisal should value licensed space carefully, because the property may have few alternative users.